The natural protein kinase C alpha mutant is present in human thyroid neoplasms.

Abstract:

:An altered protein expression of Ca(2+)-dependent protein kinase C (PKC) isoforms and a point mutation in the PKC alpha cDNA (position 908 of the nucleotide sequence, position 294 of the amino acid sequence, substitution of an aspartic acid by a glycine) have been previously described in a subpopulation of human pituitary tumors. In this work, we screened 16 thyroid tissue samples (four follicular adenomas, five colloid adenomas, three papillary carcinomas, one follicular carcinoma and three normal tissues adjacent to the tumors) for the presence of the PKC alpha point mutation and for PKC alpha, beta 1, beta 2, epsilon and delta protein expression. Screening for the presence of the PKC alpha mutant was performed by a subcloning technic. The polymerase chain reaction products were generated using reverse-transcribed cDNAs, subcloned and sequenced (10 clones were routinely sequenced). The PKC alpha point mutation at position 908 of the cDNA sequence was found in four out of the nine adenomas and in the follicular carcinoma. It was neither detected in the papillary carcinomas nor in the adjacent normal tissues (one was the adjacent normal tissue of the follicular carcinoma; in this sample, genomic DNA and cDNA were used to look for the presence of the mutant), demonstrating the somatic nature of this mutant. Western blot analysis of PKC isoforms showed that the expression of all isoforms was higher in the thyroid neoplasms as compared with their adjacent normal tissue (n = 3). It was also higher in the samples containing the PKC mutant (two follicular adenomas, two colloid adenomas and the follicular carcinoma) as compared with the tumors where it was not detected (three papillary carcinomas and five adenomas). Samples could be ordered according to their increasing PKC expression as follows: normal adjacent tissue < follicular adenomas without PKC alpha mutant < or = papillary carcinoma < follicular adenomas with PKC mutant < follicular carcinoma with PKC mutant. In conclusion, the discovery of the PKC alpha mutant in thyroid neoplasms demonstrates that this mutant is not particular to human pituitary tumors where it was originally detected. It is a somatic mutation and its presence is concomitant with high levels of all of the PKC isoforms analysed. The presence of the PKC mutant in thyroid neoplasms raises the question of its importance in thyroid tumorigenesis.

journal_name

Oncogene

journal_title

Oncogene

authors

Prévostel C,Alvaro V,de Boisvilliers F,Martin A,Jaffiol C,Joubert D

subject

Has Abstract

pub_date

1995-08-17 00:00:00

pages

669-74

issue

4

eissn

0950-9232

issn

1476-5594

journal_volume

11

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels.

    abstract::Among surface molecules expressed on endothelial cells, endoglin (CD105) is emerging as a prime vascular target for antiangiogenetic cancer therapy. CD105 is a cell membrane glycoprotein mainly expressed on endothelial cells and overexpressed on tumor-associated vascular endothelium, which functions as an accessory co...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1206813

    authors: Fonsatti E,Altomonte M,Nicotra MR,Natali PG,Maio M

    更新日期:2003-09-29 00:00:00

  • The 26S proteasome system degrades the ERM transcription factor and regulates its transcription-enhancing activity.

    abstract::ERM is a member of the ETS transcription factor family. High levels of the corresponding mRNA are detected in a variety of human breast cancer cell lines, as well as in aggressive human breast tumors. As ERM protein is almost undetectable in these cells, high degradation of this transcription factor has been postulate...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209801

    authors: Baert JL,Beaudoin C,Monte D,Degerny C,Mauen S,de Launoit Y

    更新日期:2007-01-18 00:00:00

  • Kit signaling and negative regulation of daunorubicin-induced apoptosis: role of phospholipase Cgamma.

    abstract::Previous studies have demonstrated that activation of Kit by stem cell factor (SCF), its natural ligand, or by gain-of-function point mutation in its intracellular domain, confers significant protection against apoptosis induced by growth factor deprivation or radiation. However, the effects of Kit activation on the c...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204877

    authors: Plo I,Lautier D,Casteran N,Dubreuil P,Arock M,Laurent G

    更新日期:2001-10-11 00:00:00

  • Death inducer-obliterator 1 (Dido1) is a BMP target gene and promotes BMP-induced melanoma progression.

    abstract::Bone morphogenetic proteins (BMPs) are known to play an important role in melanoma development and progression. However, the downstream targets of BMPs have not been investigated thus far. Therefore, we treated melanoma cell lines with the Smad-specific BMP inhibitor Dorsomorphin and performed a cDNA microarray. We id...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.115

    authors: Braig S,Bosserhoff AK

    更新日期:2013-02-14 00:00:00

  • p53-independent association between SV40 large T antigen and the major cytosolic heat shock protein, HSP90.

    abstract::The simian double strand DNA tumor virus SV40 encodes the 90-kDa multi-functional protein, large T antigen (LT). LT functions by binding to DNA, as well as to many cellular target proteins such as p53 and retinoblastoma protein (pRB). We report here the identification of a cellular heat shock protein, HSP90, as a prev...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203475

    authors: Miyata Y,Yahara I

    更新日期:2000-03-09 00:00:00

  • NF-kappaB signaling, liver disease and hepatoprotective agents.

    abstract::The NF-kappaB signaling pathway has particular relevance to several liver diseases including hepatitis (liver infection by Helicobacter, viral hepatitis induced by HBV and HCV), liver fibrosis and cirrhosis and hepatocellular carcinoma. Furthermore, the NF-kappaB signaling pathway is a potential target for development...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2008.300

    authors: Sun B,Karin M

    更新日期:2008-10-20 00:00:00

  • DNA: leukemia's secret weapon of bone mass destruction.

    abstract::Interaction of tumour cells with their microenvironment impacts on all aspects of cancer, ranging from development through to treatment response. In this issue, Dvorak and colleagues(1) reveal a novel tumour/microenvironment relationship that may drive leukemia pathogenesis. Specifically, they find that leukemic cells...

    journal_title:Oncogene

    pub_type: 评论,杂志文章

    doi:10.1038/onc.2012.639

    authors: Tait S

    更新日期:2013-10-31 00:00:00

  • Increase in specific DNA binding by carboxyl truncation suggests a mechanism for activation of Myb.

    abstract::Oncogenic forms of the c-myb protein (Myb) often exhibit amino-terminal and/or carboxyl-terminal truncations. When the transcriptional activity of these proteins was examined it was found that carboxyl-truncated Myb is more effective as a transcriptional activator than full-length or amino-truncated Myb. In order to d...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Ramsay RG,Ishii S,Gonda TJ

    更新日期:1991-10-01 00:00:00

  • IL6 derived from cancer-associated fibroblasts promotes chemoresistance via CXCR7 in esophageal squamous cell carcinoma.

    abstract::Various factors and cellular components in the tumor microenvironment are key drivers associated with drug resistance in many cancers. Here, we analyzed the factors and molecular mechanisms involved in chemoresistance in patients with esophageal squamous cell carcinoma (ESCC). We found that interleukin 6 (IL6) derived...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2017.387

    authors: Qiao Y,Zhang C,Li A,Wang D,Luo Z,Ping Y,Zhou B,Liu S,Li H,Yue D,Zhang Z,Chen X,Shen Z,Lian J,Li Y,Wang S,Li F,Huang L,Wang L,Zhang B,Yu J,Qin Z,Zhang Y

    更新日期:2018-02-15 00:00:00

  • The interaction between caveolin-1 and Rho-GTPases promotes metastasis by controlling the expression of alpha5-integrin and the activation of Src, Ras and Erk.

    abstract::Proteins containing a caveolin-binding domain (CBD), such as the Rho-GTPases, can interact with caveolin-1 (Cav1) through its caveolin scaffold domain. Rho-GTPases are important regulators of p130(Cas), which is crucial for both normal cell migration and Src kinase-mediated metastasis of cancer cells. However, althoug...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.288

    authors: Arpaia E,Blaser H,Quintela-Fandino M,Duncan G,Leong HS,Ablack A,Nambiar SC,Lind EF,Silvester J,Fleming CK,Rufini A,Tusche MW,Brüstle A,Ohashi PS,Lewis JD,Mak TW

    更新日期:2012-02-16 00:00:00

  • Physical interaction of estrogen receptor with MnSOD: implication in mitochondrial O2.- upregulation and mTORC2 potentiation in estrogen-responsive breast cancer cells.

    abstract::Augmented reactive oxygen species levels consequential to functional alteration of key mitochondrial attributes contribute to carcinogenesis, either directly via oxidative DNA damage infliction or indirectly via activation of oncogenic signaling cascades. We previously reported activation of a key oncogenic signaling ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.346

    authors: Lone MU,Baghel KS,Kanchan RK,Shrivastava R,Malik SA,Tewari BN,Tripathi C,Negi MP,Garg VK,Sharma M,Bhatt ML,Bhadauria S

    更新日期:2017-03-30 00:00:00

  • Expression of the receptor tyrosine kinase substrate genes eps8 and eps15 during mouse development.

    abstract::Receptor tyrosine kinases (RTKs) control proliferation and differentiation through their ability to bind and/or phosphorylate intracellular substrates. The repertoire of substrates recruited by different RTK is largely overlapping. It is not clear, therefore, how a cell distinguishes among signals originating from dif...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Avantaggiato V,Torino A,Wong WT,Di Fiore PP,Simeone A

    更新日期:1995-09-21 00:00:00

  • Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.

    abstract::In the present study, we have analysed the effects of transforming growth factor-beta (TGF-beta) signaling on the growth behavior of pancreatic carcinoma cells in vitro and on their tumorigenicity in vivo. Ectopic expression of dominant-negative mutants of the TGF-beta type II receptor or type I receptor/activin recep...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210272

    authors: Schniewind B,Groth S,Sebens Müerköster S,Sipos B,Schäfer H,Kalthoff H,Fändrich F,Ungefroren H

    更新日期:2007-07-19 00:00:00

  • Alanine mutagenesis of conserved residues in the platelet-derived growth factor family: identification of residues necessary for dimerization and transformation.

    abstract::Platelet-derived growth factor (PDGF) and vascular endothelial growth factor define a family of dimeric proteins characterized by eight conserved cysteine residues involved in disulfide bonds. Thirteen non-cysteine residues conserved among the platelet-derived/vascular endothelial growth factors were individually muta...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Maher DW,Strawn LM,Donoghue DJ

    更新日期:1993-03-01 00:00:00

  • Oncogenic Ras-induced secretion of a novel inhibitor of skeletal myoblast differentiation.

    abstract::Expression of oncogenic H-Ras in 23A2 myoblasts (A2:H-Ras cells) is sufficient to induce both a transformed phenotype and a differentiation-defective phenotype. Because oncogenic Ras is known to induce the secretion of several different growth factors involved in maintaining the transformed phenotype of both fibroblas...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201423

    authors: Weyman CM,Wolfman A

    更新日期:1997-11-20 00:00:00

  • Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria.

    abstract::A key hallmark of many cancers, particularly the most aggressive, is the capacity to metabolize glucose at an elevated rate, a phenotype detected clinically using positron emission tomography (PET). This phenotype provides cancer cells, including those that participate in metastasis, a distinct competitive edge over n...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1209603

    authors: Mathupala SP,Ko YH,Pedersen PL

    更新日期:2006-08-07 00:00:00

  • Molecular cloning and characterization of the t(2;14) translocation associated with childhood chronic lymphocytic leukemia.

    abstract::Two rare cases of chronic lymphocytic leukemia (CLL) in children, patients AS and LH, have been found to be associated with a unique chromosomal translocation, t(2;14)(p13;q32). Previous studies have shown the breakpoints of this translocation to be in the gamma 2 switch region of the Ig heavy-chain locus on chromosom...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Richardson AL,Humphries CG,Tucker PW

    更新日期:1992-05-01 00:00:00

  • Activation of the colony-stimulating factor 1 receptor leads to the rapid tyrosine phosphorylation of GTPase-activating protein and activation of cellular p21ras.

    abstract::We have previously reported that platelet-derived growth factor (PDGF) induced tyrosine phosphorylation of GTPase-activating protein (GAP) in intact quiescent fibroblasts under conditions in which insulin and basic fibroblast growth factor (bFGF) were ineffective (Molloy et al., 1988). In the present study, we have pr...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Heidaran MA,Molloy CJ,Pangelinan M,Choudhury GG,Wang LM,Fleming TP,Sakaguchi AY,Pierce JH

    更新日期:1992-01-01 00:00:00

  • Upregulation of histamine receptor H1 promotes tumor progression and contributes to poor prognosis in hepatocellular carcinoma.

    abstract::H1 histamine receptor (H1HR) belongs to the family of rhodopsin-like G-protein-coupled receptors. Recent studies have shown that H1HR expression is increased in several types of cancer. However, its functional roles in tumor progression remain largely unknown, especially in hepatocellular carcinoma (HCC). We found tha...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-1093-y

    authors: Zhao J,Hou Y,Yin C,Hu J,Gao T,Huang X,Zhang X,Xing J,An J,Wan S,Li J

    更新日期:2020-02-01 00:00:00

  • PKCmu prevents CD95-mediated apoptosis and enhances proliferation in pancreatic tumour cells.

    abstract::Loss of growth control and a marked resistance to apoptosis are considered major mechanisms driving tumour progression. Protein kinases C (PKC) have been shown to be important in the regulation of proliferation and apoptosis. In this report, we investigated the role of the PKC-like kinase PKCmu in the control of these...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207001

    authors: Trauzold A,Schmiedel S,Sipos B,Wermann H,Westphal S,Röder C,Klapper W,Arlt A,Lehnert L,Ungefroren H,Johannes FJ,Kalthoff H

    更新日期:2003-12-04 00:00:00

  • Retinoid-dependent antagonism of serum response factor transactivation mediated by transcriptional coactivator proteins.

    abstract::Transcriptional coactivators SRC-1 and p300 specifically interact with liganded-nuclear receptors and also modulate other transcription factors, including serum response factor (SRF). Here, we report that retinoids repress transactivation by SRF and specific interactions exist between the DNA binding domains of SRF an...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204695

    authors: Kim SW,Kim HJ,Jung DJ,Lee SK,Kim YS,Kim JH,Kim TS,Lee JW

    更新日期:2001-10-04 00:00:00

  • Site-specific DNA methylation by a complex of PU.1 and Dnmt3a/b.

    abstract::The Ets transcription factor PU.1 is a hematopoietic master regulator essential for the development of myeloid and B-cell lineages. As we previously reported, PU.1 sometimes represses transcription on forming a complex with mSin3A-histone deacetyl transferase-MeCP2. Here, we show an interaction between PU.1 and DNA me...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209272

    authors: Suzuki M,Yamada T,Kihara-Negishi F,Sakurai T,Hara E,Tenen DG,Hozumi N,Oikawa T

    更新日期:2006-04-20 00:00:00

  • EGFR-STAT3 signaling promotes formation of malignant peripheral nerve sheath tumors.

    abstract::Malignant peripheral nerve sheath tumors (MPNSTs) develop sporadically or in the context of neurofibromatosis type 1. Epidermal growth factor receptor (EGFR) overexpression has been implicated in MPNST formation, but its precise role and relevant signaling pathways remain unknown. We found that EGFR overexpression pro...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.579

    authors: Wu J,Patmore DM,Jousma E,Eaves DW,Breving K,Patel AV,Schwartz EB,Fuchs JR,Cripe TP,Stemmer-Rachamimov AO,Ratner N

    更新日期:2014-01-09 00:00:00

  • Allelic loss at 7q31.1 in human primary ovarian carcinomas suggests the existence of a tumor suppressor gene.

    abstract::We studied loss of heterozygosity (LOH) in chromosome 7q in order to determine the location of a putative tumor suppressor gene (TSG) in human epithelial ovarian carcinomas. Samples were obtained from 26 primary ovarian carcinomas at the time of staging laparotomy. Paired normal and tumoral DNAs were used as templates...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Zenklusen JC,Weitzel JN,Ball HG,Conti CJ

    更新日期:1995-07-20 00:00:00

  • OTUB1 inhibits the ubiquitination and degradation of FOXM1 in breast cancer and epirubicin resistance.

    abstract::The forkhead transcription factor FOXM1 has a key role in DNA damage response, and its deregulated overexpression is associated with genotoxic drug resistance in breast cancer. However, little is known about the posttranslational mechanisms by which FOXM1 expression is regulated by genotoxic agents and how they are de...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2015.208

    authors: Karunarathna U,Kongsema M,Zona S,Gong C,Cabrera E,Gomes AR,Man EP,Khongkow P,Tsang JW,Khoo US,Medema RH,Freire R,Lam EW

    更新日期:2016-03-17 00:00:00

  • Opposing roles of angiomotin-like-1 and zona occludens-2 on pro-apoptotic function of YAP.

    abstract::YAP (Yes-associated protein) oncogene has been found to form a stable complex with members of the Angiomotin (Amot) family of proteins, which bind WW domains of YAP and sequester the protein in the cytoplasm and junctional complexes. The Amot-mediated retention of YAP in the cytoplasm results in the inhibition of its ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.216

    authors: Oka T,Schmitt AP,Sudol M

    更新日期:2012-01-05 00:00:00

  • A pancreatic cancer-specific expression profile.

    abstract::We present an approach making use of technology established in the context of the genome project to describe a pancreatic cancer-specific expression profile and to identify new potential disease genes or disease-associated-genes. By use of gridded arrays of pancreatic cancer cDNA libraries and differential hybridizati...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Gress TM,Müller-Pillasch F,Geng M,Zimmerhackl F,Zehetner G,Friess H,Büchler M,Adler G,Lehrach H

    更新日期:1996-10-17 00:00:00

  • The Shb signalling scaffold binds to and regulates constitutive signals from the Epstein-Barr virus LMP2A membrane protein.

    abstract::The Epstein-Barr virus latency-associated membrane protein LMP2A has been shown to activate the survival kinase Akt in epithelial and B cells in a phosphoinositide 3-kinase-dependent fashion. In this study, we demonstrate that the signalling scaffold Shb associates through SH2 and PTB domain interactions with phosphor...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210298

    authors: Matskova LV,Helmstetter C,Ingham RJ,Gish G,Lindholm CK,Ernberg I,Pawson T,Winberg G

    更新日期:2007-07-26 00:00:00

  • Drosophila actin-Capping Protein limits JNK activation by the Src proto-oncogene.

    abstract::The Src family kinases c-Src, and its downstream effectors, the Rho family of small GTPases RhoA and Jun N-terminal kinase (JNK) have a significant role in tumorigenesis. In this report, using the Drosophila wing disc epithelium as a model system, we demonstrate that the actin-Capping Protein (CP) αβ heterodimer, whic...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.155

    authors: Fernández BG,Jezowska B,Janody F

    更新日期:2014-04-17 00:00:00

  • Expression of p66(Shc) protein correlates with proliferation of human prostate cancer cells.

    abstract::p66(Shc), an isoform of Shc adaptor proteins, is shown to mediate various signals, including cellular stress. However, little is known about its involvement in carcinogenesis. We previously showed that p66(Shc) protein level is upregulated by steroid hormones in human carcinoma cells and is higher in prostate cancer (...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208852

    authors: Veeramani S,Igawa T,Yuan TC,Lin FF,Lee MS,Lin JS,Johansson SL,Lin MF

    更新日期:2005-11-03 00:00:00